Why AbbVie (ABBV) Outpaced the Stock Market Today
Why AbbVie (ABBV) Outpaced the Stock Market Today Yahoo Finance Singapore
Covered in this story
Analyst targets on AbbVie
- Bank of America: $262 → $289 by Sep 2027 · Buy via AOL.com
- Guggenheim: $244 → $288 by Aug 2027 · Buy via GuruFocus
- Canaccord Genuity: $245 → $290 by Aug 2027 via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Dalsna Finance is currently tracking 49 stories mentioning AbbVie, the earliest published 11 Jun 2026.
Summary aggregated from Yahoo Finance Singapore's public RSS feed. The full reporting belongs to Yahoo Finance Singapore — please read it on their site.